Development of anthracycline-induced dilated cardiomyopathy due to mutation on LMNA gene in a breast cancer patient: a case report

BACKGROUND: Anthracyclines are highly effective anticancer medication prescribed for the treatment of breast cancer. Nevertheless, the use of anthracyclines as chemotherapeutic agents involves a risk for development of cardiac toxicity which may cause restrictive and dilated cardiomyopathy. Currentl...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuruc, Jock Chichaco, Durant-Archibold, Armando A., Motta, Jorge, Rao, K. S., Trachtenberg, Barry, Ramos, Carlos, Wang, Hongyu, Gorenstein, David, Vannberg, Fredrik, Jordan, King
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6636154/
https://www.ncbi.nlm.nih.gov/pubmed/31311496
http://dx.doi.org/10.1186/s12872-019-1155-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6636154/
https://www.ncbi.nlm.nih.gov/pubmed/31311496
http://dx.doi.org/10.1186/s12872-019-1155-7

Ejemplares similares